Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode™ Whole Transcriptome ...

BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study ...

Researchers studying gene expression have access to vast amounts of data from cells or tissues. This is thanks to advances in bulk and single-cell RNA-sequencing (RNA-seq) technologies that can ...

Single cell sequencing reveals T follicular helper cells as the link between combination ICI therapy and the development of increased IRAEs. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...

RNA sequencing has emerged as a powerful supplement to DNA sequencing for Mendelian disease diagnosis, but clinical translation of diagnostic RNA-seq has not been widely achieved. Researchers at ...